Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.

S. Alavian | R. Malekzadeh | V. Wong | M. Manns | F. Tacke | M. Buti | J. Lazarus | H. Poustchi | B. Cowie | J. Mossong | R. Marinho | F. Sanai | F. Negro | C. Stedman | L. Roberts | M. A. Yusuf | Ding‐Shinn Chen | Hwai I. Yang | M. Yuen | A. Hatzakis | H. Razavi | Z. Abbas | V. Saraswat | Samir R. Shah | G. Shiha | S. Tan | H. Chan | R. Mohamed | J. Layden | S. Zeuzem | C. Sarrazin | W. Laleman | S. Merat | V. T. Nguyen | M. Choi | U. Akarca | S. Mauss | D. Kershenobich | M. Brunetto | I. Waked | B. Müllhaupt | N. Janjua | R. Chien | C. Cunningham | R. Flisiak | P. Arkkila | J. Tanaka | H. Vlierberghe | R. Njouom | K. Athanasakis | O. Opare-Sem | Y. Lim | H. Reesink | A. Vince | Christophe Moreno | C. Hézode | A. Craxì | R. Safadi | P. Ocama | N. Méndez-Sánchez | S. Roberts | P. Stärkel | M. Nguyen | N. Örmeci | A. Albillos | V. Sypsa | S. Vella | M. Pessoa | M. Cornberg | J. Jaroszewicz | A. Goldiş | P. Bruggmann | K. Falconer | M. Krajden | B. Hajarizadeh | R. Gray | M. El-Sayed | M. Maticic | G. Papatheodoridis | W. Chuang | H. Qureshi | A. Sharara | E. Croes | V. Liakina | P. Jarčuška | A. Nersesov | J. Gerstoft | P. Damme | C. Loo | W. Sievert | A. Hoepelman | S. Ryder | C. Yang | A. Bane | S. Kaymakoğlu | J. Mokhbat | C. Seguin-Devaux | V. Chulanov | Z. Ben‐Ari | M. Colombo | S. Dražilová | A. Yosry | M. Memon | A. Ramji | Faryal Al Lawati | Said A. Al-Busafi | K. Tomasiewicz | J. García-Samaniego | A. Bizri | C. Estes | I. Gamkrelidze | J. Arends | P. Christensen | N. Weis | A. Rached | M. Clausen | S. Aleman | M. L. Ferraz | W. Lao | A. Anand | F. Alfaleh | H. Al-Ashgar | K. Razavi-Shearer | F. Mourad | R. Jahis | G. Gaeta | J. Sperl | P. Husa | S. Oguche | I. Hrstic | Manik Sharma | C. Opio | N. Walsh | R. Salupere | C. Mello | S. Blach | J. Genov | B. Lukšić | A. Metwally | S. Robbins | O. Sagalova | A. Aljumah | I. Aho | Tesia Shin | S. Himatt | L. Kondili | P. Kristian | N. Pimenov | I. Schreter | I. Gountas | Y. Hui | K. Naamani | H. Desalegn | D. Adda | A. Nawaz | S. Alawadhi | F. Hasan | C. Yaghi | A. Mamatkulov | N. T. Anh | J. Schmelzer | K. Yesmembetov | A. Malu | P. Urbánek | E. Musabaev | S. Brandon | B. Bright | D. Cuellar | A. Konysbekova | K. Murphy | H. Nde | S. Obekpa | O. Omede | C. Omuemu | B. Redae | P. Ferreira | R. Ntagirabiri | J. Woodring | A. Chaudhry | Julia E. Scott | Z. Nurmatov | M. Correa | K. Pasini | Steve S Egeonu | T. D. Quang | G. Rjašková | Mei‐Hsuan Lee | Maheeba Abdulla | S. Fraňková | J. Sánchez-Ávila | C. Ríos | A. J. Meer | D. Razavi‐Shearer | T. Berg | Yasir Waheed | Ann-Sofi Duberg | I. Schréter | K. A. Naamani | Zuridin S Nurmatov | D. Adda

[1]  S. Alavian,et al.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.

[2]  T. Hallett,et al.  Requirements for global elimination of hepatitis B: a modelling study. , 2016, The Lancet. Infectious diseases.

[3]  A. Kramvis.  The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics , 2016, Reviews in medical virology.

[4]  R. Mikolajczyk,et al.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 , 2015, The Lancet.

[5]  R. Lester,et al.  Test uptake and case detection of syphilis, HIV, and hepatitis C among women undergoing prenatal screening in British Columbia, 2007 to 2011. , 2014, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[6]  V. Hope,et al.  Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association , 2013, Epidemiology and Infection.

[7]  Alan D. Lopez,et al.  Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[8]  K. Kowdley,et al.  Prevalence of chronic hepatitis B among foreign‐born persons living in the United States by country of origin , 2012, Hepatology.

[9]  Gretchen A. Stevens,et al.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. , 2012, Vaccine.

[10]  Chien-Jen Chen,et al.  Natural history of chronic hepatitis B REVEALed , 2011, Journal of gastroenterology and hepatology.

[11]  C. Chu,et al.  HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long‐term follow‐up , 2007, Hepatology.

[12]  M. Raptopoulou-Gigi,et al.  Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[13]  J. Koskinas,et al.  Natural history of chronic HBV infection: A cohort study with up to 12 years follow‐up in North Greece (part of the Interreg I‐II/EC‐project) , 2005, Journal of medical virology.

[14]  Y. N. Park,et al.  Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. , 2005, Journal of hepatology.

[15]  G. Xia,et al.  Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992 , 1996 .

[16]  S. Kaneko,et al.  Clearance of HBsAg in seven patients with chronic hepatitis B , 1992, Hepatology.

[17]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.

[18]  H. Reesink,et al.  PREVENTION OF THE HBsAg CARRIER STATE IN NEWBORN INFANTS OF MOTHERS WHO ARE CHRONIC CARRIERS OF HBsAg AND HBeAg BY ADMINISTRATION OF HEPATITIS-B VACCINE AND HEPATITIS-B IMMUNOGLOBULIN Double-blind Randomised Placebo-controlled study , 1984, The Lancet.

[19]  B. Yvonnet,et al.  SIMULTANEOUS ADMINISTRATION OF HEPATITIS B AND DIPHTHERIA/TETANUS/POLIO VACCINES , 1984, The Lancet.

[20]  H. Alter,et al.  A "NEW" ANTIGEN IN LEUKEMIA SERA. , 1965, JAMA.

[21]  D. Malcolm,et al.  Application of a Technique for Research and Development Program Evaluation , 1959 .

[22]  R. Mikolajczyk,et al.  Time trends of chronic HBV infection over prior decades - A global analysis. , 2017, Journal of hepatology.

[23]  Un Desa.  Transforming our world : The 2030 Agenda for Sustainable Development , 2016 .